NCT04985838

Brief Summary

A mixed methods randomised controlled pilot trial, conducted in miniature of future definitive trial, in which the investigators will test optimised intervention and study processes. The investigators will individually randomise stroke survivor participants in a 1:1 allocation to: HEADS: UP or Control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2021

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 2, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

1.2 years

First QC Date

July 6, 2021

Last Update Submit

March 27, 2023

Conditions

Keywords

StrokeCVAAnxietyDepressionMindfulnessMBSROnlineSelf-managementMixed methods

Outcome Measures

Primary Outcomes (3)

  • Beck Depression Inventory II (change being assessed)

    The Beck Depression Inventory II is a 21-item self-report scale to assess the intensity of depression. Each item is a list of four statements arranged in increasing severity about a symptom of depression. Score range between 0-63 with higher score indicating greater severity.

    Weeks 0, 8, 20, 32 (assessing change)

  • Beck Anxiety Inventory (change being assessed)

    The Beck Anxiety Inventory is a self-report 21-item scale for measuring anxiety. The questions ask about symptoms of anxiety the subject has had during the past week. Each question is scored between 0 (mild) and 3 (severe) and a total score will vary between 0-63. Higher scores indicate more severe anxiety symptoms.

    Weeks 0, 8, 20, 32 (assessing change)

  • Depression Anxiety Stress Scales (change being assessed)

    The Depression Anxiety Stress Scale is a 21-item version of the full 42-item scale, consisting of a set of three self-report scales designed to measure depression, anxiety and stress. Each of the three DASS-21 scales contains 7 items. Participants are asked to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week. Scores for Depression, Anxiety and Stress are calculated by summing the scores for the relevant items and multiplying by two to produce the equivalent DASS-42 score. Higher scores suggesting more severe difficulties.

    Weeks 0, 8, 20, 32 (assessing change)

Secondary Outcomes (2)

  • Short Form Stroke Impact Scale (change being assessed)

    Weeks 0, 8, 20, 32 (assessing change)

  • EQ-5D 5L (change being assessed)

    Weeks 0, 8, 20, 32 (assessing change)

Study Arms (2)

Online HEADS: UP

EXPERIMENTAL

A group-based Mindfulness Based Stress Reduction (MBSR) course adapted for people affected by stroke and delivered using a video communication platform e.g. Zoom. An informal introductory session in the first week is followed by 8 weekly sessions (2.5 hours, incorporating 30-minute comfort breaks). A 6-hour silent retreat is offered in week 7. An optional follow-up session is offered six-eight weeks after completion of the 9-week course.

Behavioral: HEADS: UP (Helping Ease Anxiety and Depression)

Control

NO INTERVENTION

No intervention provided.

Interventions

A group-based Mindfulness Based Stress Reduction (MBSR) course adapted for people affected by stroke and delivered online using a video communication platform. An introductory session in the first week is followed by 8 weekly sessions (2.5 hours, incorporating 30-minute comfort breaks). A 6-hour silent retreat is offered in week 7. An optional follow-up session is offered six-eight weeks after completion of the 9-week course. Course materials include a manual (provided after the introductory session), weekly pre/post-session emails with instructions and information about joining the sessions and engaging in personal practice, including links to audio files to complement class-based sessions.

Online HEADS: UP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥18 years
  • Have had ≥1 stroke at least 3 months previously
  • Able to speak and understand conversational English DESIRABLE BUT NOT ESSENTIAL: Able to identify a family member\* who would: like to take part and can speak and understand conversational English.
  • Family member: we use an inclusive definition of 'family': 'a self-identified group of two or more individuals who consider themselves as 'family' e.g. spouse, parent, friend. When we refer to 'family' in this document our meaning extends beyond 'family', to friends, peers and volunteers/buddies.

You may not qualify if:

  • Prior MBSR attendance in the last three years (as this may confound results)
  • Current participant in another trial of a similar psychological self-management intervention
  • Currently receiving treatment for PTSD (post traumatic stress disorder) or psychosis
  • Disclosing suicidal ideation
  • Cannot follow a 2-stage command e.g. Please spell your surname and then tell me the days of the week; Please count to six and then spell your first name.
  • Scores \<3 on the PHQ-4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glasgow Caledonian University

Glasgow, Glasgow (City Of), G4 0BA, United Kingdom

Location

MeSH Terms

Conditions

StrokeAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Maggie Lawrence, PhD

    Glasgow Caledonian University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A mixed methods randomised controlled pilot trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2021

First Posted

August 2, 2021

Study Start

June 28, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

March 28, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Anonymous individual participant data will be shared by request with other researchers for ethically approved research purposes.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be available after publication of the research report and for a period of five years.
Access Criteria
By request from Maggie Lawrence maggie.lawrence@gcu.ac.uk

Locations